Use of checkpoint inhibitor pembrolizumab has continued to grow since its approval in 2014. Rare instances of conduction side effects have been described including brady and tachyarrhythmias, heart block and even cardiac arrest. We present a case of Pembrolizumab induced myocarditis and persistent third-degree heart block.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11259476 | PMC |
| http://dx.doi.org/10.55729/2000-9666.1329 | DOI Listing |
Publication Analysis
Top Keywords
heart block
12
case pembrolizumab
8
pembrolizumab induced
8
induced myocarditis
8
case case
4
myocarditis complete
4
complete heart
4
block checkpoint
4
checkpoint inhibitor
4
inhibitor pembrolizumab
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!